Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Making the Promise of Immunotherapeutics into Reality

Posted on August 2nd, 2017 by in Chemistry

This is an exciting and hopeful time for cancer research, as new therapies and approaches are being explored that offer an alternative to standard chemotherapy, which can be effective but often carries a number of harsh side effects. Continue reading “Making the Promise of Immunotherapeutics into Reality” »

Start-up Spotlight: Proteios

Posted on November 11th, 2016 by in Pharma R&D

This week’s Start-Up Spotlight, featuring start-ups in the pharmaceutical and biotech spaces, is┬áshowcasing the Seattle-based firm Proteios. Dr. Bob Snyder, Managing Director of Proteios, discusses the company and its game-changing research. Continue reading “Start-up Spotlight: Proteios” »

Immune Checkpoints: New Promises in Cancer Treatment

Posted on October 26th, 2016 by in Pharma R&D

Cancer immunotherapy (especially checkpoint inhibitors) is hot in the cancer therapeutics world, but we are still learning about how best to use them and in which patients. The current explosion in new cancer immunotherapies relates to braking T-cell activation: checkpoint therapies. Continue reading “Immune Checkpoints: New Promises in Cancer Treatment” »

Top 10 Most Talked-About Articles on Zika

Posted on September 21st, 2016 by in Pharma R&D

The Zika virus (ZIKV) has been linked to severe birth defects, causing fear of the virus around the globe. As people, particularly pregnant women, take measures to protect themselves from exposure to mosquitos that might be carrying Zika, scientists are working hard to better understand the nature of the virus Continue reading “Top 10 Most Talked-About Articles on Zika” »